AXSOME THERAPEUTICS, INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
AXSOME THERAPEUTICS, INC. (AXSM) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 2.37 million shares for the 1-month period ending 2015-11-30, per its 10-Q filed 2016-11-14.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2016-11-14
- 2015-11-30: Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month 2.37M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month |
|---|---|
| 2015-11-30 | 2.37M shares 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |